Logo image
Positive Affect and Well-Being in Huntington's Disease Moderates the Association Between Functional Impairment and HRQOL Outcomes
Journal article   Peer reviewed

Positive Affect and Well-Being in Huntington's Disease Moderates the Association Between Functional Impairment and HRQOL Outcomes

Rebecca E Ready, Nicholas R Boileau, Stacey K Barton, Jin-Shei Lai, Michael K McCormack, David Cella, Nora E Fritz, Jane S Paulsen and Noelle E Carlozzi
Journal of Huntington's disease, Vol.8(2), pp.221-232
2019
DOI: 10.3233/JHD-180341
PMCID: PMC7008959
PMID: 31045519
url
https://www.ncbi.nlm.nih.gov/pmc/articles/7008959View
Open Access

Abstract

Positive affect is associated with resiliency and beneficial health outcomes, but little is known about associations between positive affect and health-related quality of life (HRQOL) in Huntington's disease (HD). This longitudinal study determined the association between positive affect and several HRQOL outcomes in persons with HD. Functional status was examined as a moderator of the association between positive affect and HRQOL. Participants, with premanifest (i.e., genetically at risk but no clinical diagnosis, n = 50) and manifest HD (early-stage n = 171; late-stage n = 101), completed a measure of positive affect and well-being and several HRQOL measures at baseline, 12-, and 24-month follow-ups. UHDRS Functional Assessment scale indicated functional status. Positive affect was associated with better HRQOL for persons with premanifest and manifest HD over the 24-month time frame. These associations were moderated by functional status. For persons with higher functional status, positive affect was associated with better HRQOL, including less depression, lower anxiety, less anger, better social role satisfaction, better executive functions, greater upper extremity function, less dyscontrol, and less concern with death and dying. For persons with lower functional status, positive affect was not associated with HRQOL. Positive affect predicted better self-reported HRQOL over a 24-month period in persons with premanifest and manifest HD, particularly when participnats had better functional status. Interventions to enhance positive affect in HD may have beneficial effects on HRQOL.
Disability Evaluation Humans Middle Aged Huntington Disease - psychology Adult Female Male Quality of Life - psychology Affect Longitudinal Studies

Details

Metrics

Logo image